MAIA Biotechnology Inc., a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer ...

Silo Pharma Inc. has entered into a non-binding letter of intent to form a strategic 50:50 joint venture with Hoth ...

Bio-Thera Solutions and SteinCares have signed a new agreement to commercialize a proposed biosimilar of dupilumab across ...

Precision BioSciences, Inc. received a Rare Pediatric Disease Designation from the U.S. Food and Drug Administration (FDA) for PBGENE-DMD to treat Duchenne muscular dystrophy (DMD).

Gilead Sciences Inc. and Kymera Therapeutics Inc. have entered into an exclusive option and license agreement.

Amzal is a statistician, public health scientist, and entrepreneur with more than 25 years of experience across biotech and ...

Xcell Biosciences, an instrumentation company focused on cell and gene therapy applications, has partnered with Thermo Fisher ...

GSK’s approval expands belimumab treatment options, offering a first-of-its-kind subcutaneous option that can be administered ...

Starton Therapeutics Inc., a clinical-stage biotechnology company, has entered into a collaboration agreement with Bend Bioscience.

Novo Nordisk has ended its partnership with Hims & Hers Health Inc., citing “deceptive marketing” and the selling of ...

Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK. The opening ceremony was ...

Cellular Origins has entered into a collaboration with Johnson & Johnson to develop a scalable, end-to-end automated platform ...